Literature DB >> 8397505

Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase.

Y Yura1, H Yoshida, M Sato.   

Abstract

Genistein, an inhibitor of protein-tyrosine kinase, inhibited the replication of herpes simplex virus type 1 (HSV-1) at genistein concentrations of more than 25 microM, whereas the related compounds, which do not inhibit protein-tyrosine kinases, did not affect the replication of HSV-1. In the presence of genistein, the phosphorylation of tyrosine residues in specific viral polypeptides was markedly reduced. These results indicate that the phosphorylation of tyrosine residues in viral polypeptides may be essential for the replication of HSV-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397505     DOI: 10.1007/bf01309554

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  26 in total

1.  Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1.

Authors:  D I Cohen; Y Tani; H Tian; E Boone; L E Samelson; H C Lane
Journal:  Science       Date:  1992-04-24       Impact factor: 47.728

2.  Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.

Authors:  T Watanabe; K Kondo; M Oishi
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

3.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

4.  Effects of the epipodophyllotoxin VP-16-213 on herpes simplex virus type 2 replication.

Authors:  Y Nishiyama; H Fujioka; T Tsurumi; N Yamamoto; K Maeno; S Yoshida; K Shimokata
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.

Authors:  Y Yamada; N Yamamoto; K Maeno; Y Nishiyama
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

7.  Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion.

Authors:  S Lemaster; B Roizman
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

8.  The herpes simplex virus 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies.

Authors:  M Ackermann; D K Braun; L Pereira; B Roizman
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA.

Authors:  K W Wilcox; A Kohn; E Sklyanskaya; B Roizman
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more
  13 in total

1.  Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Authors:  Naveen Kumar; Nishi R Sharma; Hinh Ly; Tristram G Parslow; Yuying Liang
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells.

Authors:  Nancy Y Villa; Eric Bartee; Mohamed R Mohamed; Masmudur M Rahman; John W Barrett; Grant McFadden
Journal:  Virology       Date:  2010-03-24       Impact factor: 3.616

3.  Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses.

Authors:  Kristin M Bedard; Myra L Wang; Sean C Proll; Yueh-Ming Loo; Michael G Katze; Michael Gale; Shawn P Iadonato
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

5.  Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication.

Authors:  Naveen Kumar; Yuhong Liang; Tristram G Parslow; Yuying Liang
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

6.  The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection.

Authors:  J E Strong; P W Lee
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions.

Authors:  X Ren; J S Harms; G A Splitter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Herpes simplex virus-type 2 infectivity and agents that block gap junctional intercellular communication.

Authors:  Maureen T Knabb; Casey A Danielsen; Kerry McShane-Kay; Gustave K N Mbuy; Richard I Woodruff
Journal:  Virus Res       Date:  2006-12-08       Impact factor: 3.303

9.  Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1.

Authors:  Y Yura; J Kusaka; Y Kondo; H Tsujimoto; H Yoshida; M Sato
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 10.  Animal models, prophylaxis, and therapeutics for arenavirus infections.

Authors:  Eric Vela
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.